nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—SLC22A3—Melphalan—ovarian cancer	0.365	1	CbGbCtD
Guanidine—GAMT—Vinblastine—Vinorelbine—ovarian cancer	0.00745	1	CbGdCrCtD
Guanidine—KCNH1—embryo—ovarian cancer	0.0066	0.0219	CbGeAlD
Guanidine—KCNG1—myometrium—ovarian cancer	0.00612	0.0203	CbGeAlD
Guanidine—Ataxia—Altretamine—ovarian cancer	0.00593	0.0364	CcSEcCtD
Guanidine—DLG4—myometrium—ovarian cancer	0.00532	0.0176	CbGeAlD
Guanidine—KCNS2—uterus—ovarian cancer	0.00523	0.0174	CbGeAlD
Guanidine—KCNG2—testis—ovarian cancer	0.00501	0.0166	CbGeAlD
Guanidine—KCND1—embryo—ovarian cancer	0.0049	0.0162	CbGeAlD
Guanidine—KCNG1—uterine cervix—ovarian cancer	0.00476	0.0158	CbGeAlD
Guanidine—KCNS2—female reproductive system—ovarian cancer	0.00471	0.0156	CbGeAlD
Guanidine—KCNB1—epithelium—ovarian cancer	0.00465	0.0154	CbGeAlD
Guanidine—KCNC3—epithelium—ovarian cancer	0.00451	0.015	CbGeAlD
Guanidine—KCNF1—myometrium—ovarian cancer	0.00436	0.0144	CbGeAlD
Guanidine—KCNS1—epithelium—ovarian cancer	0.00418	0.0138	CbGeAlD
Guanidine—KCNG1—uterus—ovarian cancer	0.00397	0.0132	CbGeAlD
Guanidine—DLG4—decidua—ovarian cancer	0.00394	0.0131	CbGeAlD
Guanidine—KCNS3—myometrium—ovarian cancer	0.00382	0.0127	CbGeAlD
Guanidine—KCNC4—decidua—ovarian cancer	0.00377	0.0125	CbGeAlD
Guanidine—RNASE1—myometrium—ovarian cancer	0.00371	0.0123	CbGeAlD
Guanidine—Anaemia—Altretamine—ovarian cancer	0.00351	0.0216	CcSEcCtD
Guanidine—Leukopenia—Altretamine—ovarian cancer	0.0034	0.0209	CcSEcCtD
Guanidine—KCNF1—uterine cervix—ovarian cancer	0.00339	0.0112	CbGeAlD
Guanidine—KCNV2—testis—ovarian cancer	0.00338	0.0112	CbGeAlD
Guanidine—KCND2—myometrium—ovarian cancer	0.00333	0.011	CbGeAlD
Guanidine—KCND1—gonad—ovarian cancer	0.00332	0.011	CbGeAlD
Guanidine—KCNF1—decidua—ovarian cancer	0.00323	0.0107	CbGeAlD
Guanidine—KCNH1—testis—ovarian cancer	0.00323	0.0107	CbGeAlD
Guanidine—KCNG1—vagina—ovarian cancer	0.00323	0.0107	CbGeAlD
Guanidine—DLG4—female reproductive system—ovarian cancer	0.0031	0.0103	CbGeAlD
Guanidine—KCNF1—endometrium—ovarian cancer	0.00307	0.0102	CbGeAlD
Guanidine—Thrombocytopenia—Altretamine—ovarian cancer	0.00304	0.0186	CcSEcCtD
Guanidine—KCNA5—uterine cervix—ovarian cancer	0.00303	0.0101	CbGeAlD
Guanidine—KCNS3—epithelium—ovarian cancer	0.003	0.00993	CbGeAlD
Guanidine—KCNS3—uterine cervix—ovarian cancer	0.00297	0.00985	CbGeAlD
Guanidine—KCND1—female reproductive system—ovarian cancer	0.00297	0.00984	CbGeAlD
Guanidine—Anorexia—Altretamine—ovarian cancer	0.00296	0.0181	CcSEcCtD
Guanidine—RNASE1—uterine cervix—ovarian cancer	0.00288	0.00956	CbGeAlD
Guanidine—KCNH3—testis—ovarian cancer	0.00288	0.00954	CbGeAlD
Guanidine—KCNG1—testis—ovarian cancer	0.00288	0.00954	CbGeAlD
Guanidine—DLG4—female gonad—ovarian cancer	0.00282	0.00936	CbGeAlD
Guanidine—KCNS1—vagina—ovarian cancer	0.00281	0.0093	CbGeAlD
Guanidine—KCNH8—testis—ovarian cancer	0.00279	0.00924	CbGeAlD
Guanidine—KCNQ5—female reproductive system—ovarian cancer	0.00277	0.00919	CbGeAlD
Guanidine—RNASE1—decidua—ovarian cancer	0.00275	0.00911	CbGeAlD
Guanidine—KCNC3—testis—ovarian cancer	0.00271	0.00897	CbGeAlD
Guanidine—Decreased appetite—Altretamine—ovarian cancer	0.0027	0.0166	CcSEcCtD
Guanidine—KCNS3—endometrium—ovarian cancer	0.00269	0.00891	CbGeAlD
Guanidine—KCND1—vagina—ovarian cancer	0.00268	0.0089	CbGeAlD
Guanidine—GAMT—decidua—ovarian cancer	0.00267	0.00886	CbGeAlD
Guanidine—RNASE1—endometrium—ovarian cancer	0.00261	0.00865	CbGeAlD
Guanidine—KCNA5—gonad—ovarian cancer	0.00254	0.00844	CbGeAlD
Guanidine—Folliculitis—Paclitaxel—ovarian cancer	0.00252	0.0155	CcSEcCtD
Guanidine—KCNQ5—vagina—ovarian cancer	0.00251	0.00832	CbGeAlD
Guanidine—KCNS1—testis—ovarian cancer	0.0025	0.0083	CbGeAlD
Guanidine—DLG4—testis—ovarian cancer	0.0025	0.0083	CbGeAlD
Guanidine—KCNA2—testis—ovarian cancer	0.0025	0.0083	CbGeAlD
Guanidine—KCND2—decidua—ovarian cancer	0.00247	0.00818	CbGeAlD
Guanidine—RNASE1—uterus—ovarian cancer	0.0024	0.00797	CbGeAlD
Guanidine—KCND1—testis—ovarian cancer	0.00239	0.00794	CbGeAlD
Guanidine—KCNC4—testis—ovarian cancer	0.00239	0.00794	CbGeAlD
Guanidine—KCNQ4—testis—ovarian cancer	0.0023	0.00763	CbGeAlD
Guanidine—KCNH7—testis—ovarian cancer	0.0023	0.00763	CbGeAlD
Guanidine—KCNC1—testis—ovarian cancer	0.0023	0.00763	CbGeAlD
Guanidine—KCNF1—vagina—ovarian cancer	0.0023	0.00762	CbGeAlD
Guanidine—KCNQ2—gonad—ovarian cancer	0.00229	0.0076	CbGeAlD
Guanidine—KCNA5—female reproductive system—ovarian cancer	0.00227	0.00754	CbGeAlD
Guanidine—KCNH6—uterus—ovarian cancer	0.00226	0.00749	CbGeAlD
Guanidine—KCND3—uterine cervix—ovarian cancer	0.00226	0.00748	CbGeAlD
Guanidine—KCNQ3—female reproductive system—ovarian cancer	0.00223	0.00738	CbGeAlD
Guanidine—Throat sore—Paclitaxel—ovarian cancer	0.00219	0.0135	CcSEcCtD
Guanidine—Eruption—Docetaxel—ovarian cancer	0.00218	0.0134	CcSEcCtD
Guanidine—Oropharyngeal discomfort—Paclitaxel—ovarian cancer	0.00218	0.0134	CcSEcCtD
Guanidine—Ataxia—Chlorambucil—ovarian cancer	0.00211	0.0129	CcSEcCtD
Guanidine—KCNQ1—decidua—ovarian cancer	0.00208	0.0069	CbGeAlD
Guanidine—KCNA5—female gonad—ovarian cancer	0.00207	0.00686	CbGeAlD
Guanidine—Atrial fibrillation—Melphalan—ovarian cancer	0.00206	0.0127	CcSEcCtD
Guanidine—KCNA5—vagina—ovarian cancer	0.00206	0.00682	CbGeAlD
Guanidine—Dizziness—Altretamine—ovarian cancer	0.00205	0.0126	CcSEcCtD
Guanidine—KCNQ2—female reproductive system—ovarian cancer	0.00205	0.00679	CbGeAlD
Guanidine—RNASE1—bone marrow—ovarian cancer	0.00204	0.00676	CbGeAlD
Guanidine—KCNH6—female reproductive system—ovarian cancer	0.00203	0.00673	CbGeAlD
Guanidine—KCNS3—vagina—ovarian cancer	0.00201	0.00667	CbGeAlD
Guanidine—RNASE1—female gonad—ovarian cancer	0.00197	0.00652	CbGeAlD
Guanidine—ALDH2—myometrium—ovarian cancer	0.00196	0.00649	CbGeAlD
Guanidine—RNASE1—vagina—ovarian cancer	0.00195	0.00648	CbGeAlD
Guanidine—KCNA3—lymph node—ovarian cancer	0.00191	0.00633	CbGeAlD
Guanidine—GAMT—vagina—ovarian cancer	0.0019	0.0063	CbGeAlD
Guanidine—KCND3—uterus—ovarian cancer	0.00188	0.00624	CbGeAlD
Guanidine—KCNQ2—female gonad—ovarian cancer	0.00186	0.00618	CbGeAlD
Guanidine—Throat sore—Docetaxel—ovarian cancer	0.00186	0.0114	CcSEcCtD
Guanidine—Oropharyngeal discomfort—Docetaxel—ovarian cancer	0.00184	0.0113	CcSEcCtD
Guanidine—Nausea—Altretamine—ovarian cancer	0.00184	0.0113	CcSEcCtD
Guanidine—KCNA5—testis—ovarian cancer	0.00183	0.00608	CbGeAlD
Guanidine—DLG4—lymph node—ovarian cancer	0.00181	0.00602	CbGeAlD
Guanidine—KCNA2—lymph node—ovarian cancer	0.00181	0.00602	CbGeAlD
Guanidine—Liver function test abnormal—Melphalan—ovarian cancer	0.0018	0.0111	CcSEcCtD
Guanidine—KCNS3—testis—ovarian cancer	0.0018	0.00595	CbGeAlD
Guanidine—KCND2—female gonad—ovarian cancer	0.00176	0.00585	CbGeAlD
Guanidine—RNASE1—testis—ovarian cancer	0.00174	0.00578	CbGeAlD
Guanidine—Oropharyngeal pain—Paclitaxel—ovarian cancer	0.00174	0.0107	CcSEcCtD
Guanidine—KCNC4—lymph node—ovarian cancer	0.00174	0.00575	CbGeAlD
Guanidine—GAMT—testis—ovarian cancer	0.0017	0.00562	CbGeAlD
Guanidine—Body temperature increased—Carboplatin—ovarian cancer	0.00169	0.0104	CcSEcCtD
Guanidine—KCNQ2—testis—ovarian cancer	0.00165	0.00548	CbGeAlD
Guanidine—KCNQ1—female reproductive system—ovarian cancer	0.00164	0.00543	CbGeAlD
Guanidine—KCNQ5—lymph node—ovarian cancer	0.00162	0.00538	CbGeAlD
Guanidine—KCND2—testis—ovarian cancer	0.00157	0.00519	CbGeAlD
Guanidine—KCNQ1—bone marrow—ovarian cancer	0.00155	0.00512	CbGeAlD
Guanidine—Hallucination—Chlorambucil—ovarian cancer	0.00154	0.00948	CcSEcCtD
Guanidine—SLC22A4—myometrium—ovarian cancer	0.00153	0.00507	CbGeAlD
Guanidine—ALDH2—uterine cervix—ovarian cancer	0.00152	0.00505	CbGeAlD
Guanidine—KCNQ1—female gonad—ovarian cancer	0.00149	0.00494	CbGeAlD
Guanidine—Oropharyngeal pain—Docetaxel—ovarian cancer	0.00147	0.00906	CcSEcCtD
Guanidine—Sweating—Topotecan—ovarian cancer	0.00147	0.00905	CcSEcCtD
Guanidine—Eruption—Epirubicin—ovarian cancer	0.00147	0.00903	CcSEcCtD
Guanidine—ALDH2—decidua—ovarian cancer	0.00145	0.00481	CbGeAlD
Guanidine—Folliculitis—Epirubicin—ovarian cancer	0.00144	0.00884	CcSEcCtD
Guanidine—Lightheadedness—Paclitaxel—ovarian cancer	0.00142	0.00869	CcSEcCtD
Guanidine—SLC22A3—myometrium—ovarian cancer	0.00139	0.00461	CbGeAlD
Guanidine—ALDH2—endometrium—ovarian cancer	0.00138	0.00457	CbGeAlD
Guanidine—KCND3—testis—ovarian cancer	0.00136	0.00452	CbGeAlD
Guanidine—Eruption—Doxorubicin—ovarian cancer	0.00136	0.00835	CcSEcCtD
Guanidine—SLC22A3—embryo—ovarian cancer	0.00134	0.00444	CbGeAlD
Guanidine—Folliculitis—Doxorubicin—ovarian cancer	0.00133	0.00818	CcSEcCtD
Guanidine—KCNA5—lymph node—ovarian cancer	0.00133	0.00441	CbGeAlD
Guanidine—KCNQ1—testis—ovarian cancer	0.00132	0.00438	CbGeAlD
Guanidine—KCNS3—lymph node—ovarian cancer	0.0013	0.00432	CbGeAlD
Guanidine—ALDH2—gonad—ovarian cancer	0.00128	0.00424	CbGeAlD
Guanidine—ALDH2—uterus—ovarian cancer	0.00127	0.00421	CbGeAlD
Guanidine—Tremor—Chlorambucil—ovarian cancer	0.00127	0.00777	CcSEcCtD
Guanidine—RNASE1—lymph node—ovarian cancer	0.00126	0.00419	CbGeAlD
Guanidine—Flushing—Melphalan—ovarian cancer	0.00125	0.0077	CcSEcCtD
Guanidine—Anaemia—Chlorambucil—ovarian cancer	0.00125	0.00766	CcSEcCtD
Guanidine—GAMT—lymph node—ovarian cancer	0.00123	0.00408	CbGeAlD
Guanidine—Atrial fibrillation—Paclitaxel—ovarian cancer	0.00121	0.00744	CcSEcCtD
Guanidine—Leukopenia—Chlorambucil—ovarian cancer	0.00121	0.00742	CcSEcCtD
Guanidine—Lightheadedness—Docetaxel—ovarian cancer	0.0012	0.00737	CcSEcCtD
Guanidine—ALDH2—female reproductive system—ovarian cancer	0.00114	0.00378	CbGeAlD
Guanidine—SLC22A4—decidua—ovarian cancer	0.00113	0.00376	CbGeAlD
Guanidine—Confusional state—Chlorambucil—ovarian cancer	0.00111	0.00682	CcSEcCtD
Guanidine—Anaemia—Topotecan—ovarian cancer	0.00111	0.00682	CcSEcCtD
Guanidine—Petechiae—Epirubicin—ovarian cancer	0.0011	0.00675	CcSEcCtD
Guanidine—Flushing—Vinorelbine—ovarian cancer	0.0011	0.00673	CcSEcCtD
Guanidine—Mood swings—Paclitaxel—ovarian cancer	0.00109	0.00668	CcSEcCtD
Guanidine—Anaemia—Melphalan—ovarian cancer	0.00109	0.00668	CcSEcCtD
Guanidine—SLC22A3—uterine cervix—ovarian cancer	0.00108	0.00359	CbGeAlD
Guanidine—Ataxia—Paclitaxel—ovarian cancer	0.00108	0.00663	CcSEcCtD
Guanidine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00108	0.00663	CcSEcCtD
Guanidine—ALDH2—bone marrow—ovarian cancer	0.00108	0.00357	CbGeAlD
Guanidine—SLC22A4—endometrium—ovarian cancer	0.00108	0.00357	CbGeAlD
Guanidine—Leukopenia—Topotecan—ovarian cancer	0.00108	0.00661	CcSEcCtD
Guanidine—KCNH2—myometrium—ovarian cancer	0.00107	0.00355	CbGeAlD
Guanidine—Liver function test abnormal—Paclitaxel—ovarian cancer	0.00106	0.00651	CcSEcCtD
Guanidine—Leukopenia—Melphalan—ovarian cancer	0.00105	0.00647	CcSEcCtD
Guanidine—Anorexia—Chlorambucil—ovarian cancer	0.00105	0.00645	CcSEcCtD
Guanidine—ALDH2—female gonad—ovarian cancer	0.00104	0.00344	CbGeAlD
Guanidine—ALDH2—vagina—ovarian cancer	0.00103	0.00342	CbGeAlD
Guanidine—Atrial fibrillation—Docetaxel—ovarian cancer	0.00103	0.00631	CcSEcCtD
Guanidine—Petechiae—Doxorubicin—ovarian cancer	0.00102	0.00625	CcSEcCtD
Guanidine—SLC22A5—myometrium—ovarian cancer	0.00101	0.00335	CbGeAlD
Guanidine—KCND3—lymph node—ovarian cancer	0.000989	0.00328	CbGeAlD
Guanidine—SLC22A3—endometrium—ovarian cancer	0.000979	0.00325	CbGeAlD
Guanidine—Thrombocytopenia—Topotecan—ovarian cancer	0.00096	0.0059	CcSEcCtD
Guanidine—Decreased appetite—Chlorambucil—ovarian cancer	0.000958	0.00588	CcSEcCtD
Guanidine—KCNQ1—lymph node—ovarian cancer	0.000958	0.00318	CbGeAlD
Guanidine—Anaemia—Vinorelbine—ovarian cancer	0.00095	0.00584	CcSEcCtD
Guanidine—Hyperhidrosis—Topotecan—ovarian cancer	0.000948	0.00582	CcSEcCtD
Guanidine—Thrombocytopenia—Melphalan—ovarian cancer	0.00094	0.00578	CcSEcCtD
Guanidine—Tachycardia—Melphalan—ovarian cancer	0.000937	0.00576	CcSEcCtD
Guanidine—Anorexia—Topotecan—ovarian cancer	0.000935	0.00574	CcSEcCtD
Guanidine—ALDH2—testis—ovarian cancer	0.000921	0.00305	CbGeAlD
Guanidine—Leukopenia—Vinorelbine—ovarian cancer	0.00092	0.00565	CcSEcCtD
Guanidine—Anorexia—Melphalan—ovarian cancer	0.000916	0.00562	CcSEcCtD
Guanidine—Ataxia—Docetaxel—ovarian cancer	0.000915	0.00562	CcSEcCtD
Guanidine—Palpitations—Vinorelbine—ovarian cancer	0.000909	0.00558	CcSEcCtD
Guanidine—SLC22A3—gonad—ovarian cancer	0.000908	0.00301	CbGeAlD
Guanidine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000908	0.00558	CcSEcCtD
Guanidine—Liver function test abnormal—Docetaxel—ovarian cancer	0.000899	0.00552	CcSEcCtD
Guanidine—Hypotension—Melphalan—ovarian cancer	0.000898	0.00551	CcSEcCtD
Guanidine—SLC22A4—female reproductive system—ovarian cancer	0.000892	0.00296	CbGeAlD
Guanidine—Paraesthesia—Topotecan—ovarian cancer	0.000881	0.00541	CcSEcCtD
Guanidine—Abdominal pain—Chlorambucil—ovarian cancer	0.000871	0.00535	CcSEcCtD
Guanidine—Body temperature increased—Chlorambucil—ovarian cancer	0.000871	0.00535	CcSEcCtD
Guanidine—Paraesthesia—Melphalan—ovarian cancer	0.000863	0.0053	CcSEcCtD
Guanidine—Decreased appetite—Topotecan—ovarian cancer	0.000853	0.00524	CcSEcCtD
Guanidine—SLC22A4—bone marrow—ovarian cancer	0.000842	0.00279	CbGeAlD
Guanidine—Decreased appetite—Melphalan—ovarian cancer	0.000835	0.00513	CcSEcCtD
Guanidine—KCNH2—uterine cervix—ovarian cancer	0.000833	0.00276	CbGeAlD
Guanidine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000822	0.00505	CcSEcCtD
Guanidine—Tachycardia—Vinorelbine—ovarian cancer	0.000819	0.00503	CcSEcCtD
Guanidine—Ecchymosis—Epirubicin—ovarian cancer	0.000818	0.00502	CcSEcCtD
Guanidine—SLC22A3—female reproductive system—ovarian cancer	0.000811	0.00269	CbGeAlD
Guanidine—Feeling abnormal—Topotecan—ovarian cancer	0.000808	0.00496	CcSEcCtD
Guanidine—SLC22A4—vagina—ovarian cancer	0.000806	0.00267	CbGeAlD
Guanidine—Anorexia—Vinorelbine—ovarian cancer	0.0008	0.00491	CcSEcCtD
Guanidine—SLC22A5—uterine cervix—ovarian cancer	0.000787	0.00261	CbGeAlD
Guanidine—Hypotension—Vinorelbine—ovarian cancer	0.000784	0.00482	CcSEcCtD
Guanidine—Abdominal pain—Topotecan—ovarian cancer	0.000775	0.00476	CcSEcCtD
Guanidine—Body temperature increased—Topotecan—ovarian cancer	0.000775	0.00476	CcSEcCtD
Guanidine—SLC22A1—vagina—ovarian cancer	0.000768	0.00255	CbGeAlD
Guanidine—Ecchymosis—Doxorubicin—ovarian cancer	0.000757	0.00465	CcSEcCtD
Guanidine—Diarrhoea—Chlorambucil—ovarian cancer	0.000754	0.00463	CcSEcCtD
Guanidine—KCNH2—endometrium—ovarian cancer	0.000754	0.0025	CbGeAlD
Guanidine—Paraesthesia—Vinorelbine—ovarian cancer	0.000754	0.00463	CcSEcCtD
Guanidine—SLC22A3—female gonad—ovarian cancer	0.000738	0.00245	CbGeAlD
Guanidine—Flushing—Paclitaxel—ovarian cancer	0.000737	0.00453	CcSEcCtD
Guanidine—Vascular purpura—Epirubicin—ovarian cancer	0.000734	0.00451	CcSEcCtD
Guanidine—SLC22A3—vagina—ovarian cancer	0.000734	0.00243	CbGeAlD
Guanidine—Decreased appetite—Vinorelbine—ovarian cancer	0.000729	0.00448	CcSEcCtD
Guanidine—SLC22A5—endometrium—ovarian cancer	0.000712	0.00236	CbGeAlD
Guanidine—KCNH2—uterus—ovarian cancer	0.000694	0.0023	CbGeAlD
Guanidine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000692	0.00425	CcSEcCtD
Guanidine—Purpura—Epirubicin—ovarian cancer	0.000681	0.00418	CcSEcCtD
Guanidine—Vascular purpura—Doxorubicin—ovarian cancer	0.000679	0.00417	CcSEcCtD
Guanidine—Tension—Paclitaxel—ovarian cancer	0.000679	0.00417	CcSEcCtD
Guanidine—Nervousness—Paclitaxel—ovarian cancer	0.000672	0.00412	CcSEcCtD
Guanidine—Diarrhoea—Topotecan—ovarian cancer	0.000671	0.00412	CcSEcCtD
Guanidine—ALDH2—lymph node—ovarian cancer	0.000668	0.00221	CbGeAlD
Guanidine—Body temperature increased—Vinorelbine—ovarian cancer	0.000663	0.00407	CcSEcCtD
Guanidine—Abdominal pain—Vinorelbine—ovarian cancer	0.000663	0.00407	CcSEcCtD
Guanidine—Diarrhoea—Melphalan—ovarian cancer	0.000657	0.00404	CcSEcCtD
Guanidine—SLC22A3—testis—ovarian cancer	0.000655	0.00217	CbGeAlD
Guanidine—Nausea—Chlorambucil—ovarian cancer	0.000655	0.00402	CcSEcCtD
Guanidine—Dizziness—Topotecan—ovarian cancer	0.000649	0.00398	CcSEcCtD
Guanidine—Tremor—Paclitaxel—ovarian cancer	0.000648	0.00398	CcSEcCtD
Guanidine—Affect lability—Epirubicin—ovarian cancer	0.000646	0.00397	CcSEcCtD
Guanidine—Anaemia—Paclitaxel—ovarian cancer	0.000639	0.00393	CcSEcCtD
Guanidine—Purpura—Doxorubicin—ovarian cancer	0.00063	0.00387	CcSEcCtD
Guanidine—Flushing—Docetaxel—ovarian cancer	0.000625	0.00384	CcSEcCtD
Guanidine—KCNH2—female reproductive system—ovarian cancer	0.000624	0.00207	CbGeAlD
Guanidine—Mood swings—Epirubicin—ovarian cancer	0.000622	0.00382	CcSEcCtD
Guanidine—Leukopenia—Paclitaxel—ovarian cancer	0.000619	0.0038	CcSEcCtD
Guanidine—Rash—Topotecan—ovarian cancer	0.000619	0.0038	CcSEcCtD
Guanidine—Dermatitis—Topotecan—ovarian cancer	0.000618	0.00379	CcSEcCtD
Guanidine—Ataxia—Epirubicin—ovarian cancer	0.000617	0.00379	CcSEcCtD
Guanidine—Palpitations—Paclitaxel—ovarian cancer	0.000611	0.00375	CcSEcCtD
Guanidine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000606	0.00372	CcSEcCtD
Guanidine—Rash—Melphalan—ovarian cancer	0.000606	0.00372	CcSEcCtD
Guanidine—Dermatitis—Melphalan—ovarian cancer	0.000605	0.00372	CcSEcCtD
Guanidine—Affect lability—Doxorubicin—ovarian cancer	0.000598	0.00367	CcSEcCtD
Guanidine—SLC22A5—female reproductive system—ovarian cancer	0.00059	0.00196	CbGeAlD
Guanidine—KCNH2—bone marrow—ovarian cancer	0.000589	0.00195	CbGeAlD
Guanidine—Nausea—Topotecan—ovarian cancer	0.000583	0.00358	CcSEcCtD
Guanidine—Dry mouth—Paclitaxel—ovarian cancer	0.000576	0.00354	CcSEcCtD
Guanidine—Mood swings—Doxorubicin—ovarian cancer	0.000576	0.00353	CcSEcCtD
Guanidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000574	0.00353	CcSEcCtD
Guanidine—Ataxia—Doxorubicin—ovarian cancer	0.000571	0.00351	CcSEcCtD
Guanidine—Nausea—Melphalan—ovarian cancer	0.000571	0.0035	CcSEcCtD
Guanidine—Confusional state—Paclitaxel—ovarian cancer	0.000569	0.00349	CcSEcCtD
Guanidine—KCNH2—female gonad—ovarian cancer	0.000568	0.00188	CbGeAlD
Guanidine—KCNH2—vagina—ovarian cancer	0.000565	0.00187	CbGeAlD
Guanidine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000561	0.00344	CcSEcCtD
Guanidine—Dizziness—Vinorelbine—ovarian cancer	0.000555	0.00341	CcSEcCtD
Guanidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000553	0.00339	CcSEcCtD
Guanidine—Tachycardia—Paclitaxel—ovarian cancer	0.000551	0.00338	CcSEcCtD
Guanidine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000546	0.00335	CcSEcCtD
Guanidine—Anaemia—Docetaxel—ovarian cancer	0.000542	0.00333	CcSEcCtD
Guanidine—Anorexia—Paclitaxel—ovarian cancer	0.000538	0.0033	CcSEcCtD
Guanidine—SLC22A5—female gonad—ovarian cancer	0.000537	0.00178	CbGeAlD
Guanidine—SLC22A5—vagina—ovarian cancer	0.000534	0.00177	CbGeAlD
Guanidine—Rash—Vinorelbine—ovarian cancer	0.000529	0.00325	CcSEcCtD
Guanidine—Dermatitis—Vinorelbine—ovarian cancer	0.000529	0.00325	CcSEcCtD
Guanidine—Hypotension—Paclitaxel—ovarian cancer	0.000527	0.00324	CcSEcCtD
Guanidine—Leukopenia—Docetaxel—ovarian cancer	0.000525	0.00322	CcSEcCtD
Guanidine—SLC22A4—lymph node—ovarian cancer	0.000522	0.00173	CbGeAlD
Guanidine—Palpitations—Docetaxel—ovarian cancer	0.000518	0.00318	CcSEcCtD
Guanidine—Paraesthesia—Paclitaxel—ovarian cancer	0.000507	0.00311	CcSEcCtD
Guanidine—KCNH2—testis—ovarian cancer	0.000504	0.00167	CbGeAlD
Guanidine—Nausea—Vinorelbine—ovarian cancer	0.000498	0.00306	CcSEcCtD
Guanidine—Decreased appetite—Paclitaxel—ovarian cancer	0.000491	0.00301	CcSEcCtD
Guanidine—Dry mouth—Docetaxel—ovarian cancer	0.000488	0.003	CcSEcCtD
Guanidine—Sweating—Epirubicin—ovarian cancer	0.000485	0.00298	CcSEcCtD
Guanidine—Confusional state—Docetaxel—ovarian cancer	0.000482	0.00296	CcSEcCtD
Guanidine—SLC22A5—testis—ovarian cancer	0.000476	0.00158	CbGeAlD
Guanidine—SLC22A3—lymph node—ovarian cancer	0.000475	0.00157	CbGeAlD
Guanidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000468	0.00288	CcSEcCtD
Guanidine—Tachycardia—Docetaxel—ovarian cancer	0.000467	0.00287	CcSEcCtD
Guanidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000465	0.00286	CcSEcCtD
Guanidine—Anorexia—Docetaxel—ovarian cancer	0.000456	0.0028	CcSEcCtD
Guanidine—Sweating—Doxorubicin—ovarian cancer	0.000449	0.00276	CcSEcCtD
Guanidine—Hypotension—Docetaxel—ovarian cancer	0.000447	0.00275	CcSEcCtD
Guanidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000446	0.00274	CcSEcCtD
Guanidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000446	0.00274	CcSEcCtD
Guanidine—Paraesthesia—Docetaxel—ovarian cancer	0.00043	0.00264	CcSEcCtD
Guanidine—Flushing—Epirubicin—ovarian cancer	0.000422	0.00259	CcSEcCtD
Guanidine—Decreased appetite—Docetaxel—ovarian cancer	0.000416	0.00255	CcSEcCtD
Guanidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000394	0.00242	CcSEcCtD
Guanidine—Flushing—Doxorubicin—ovarian cancer	0.00039	0.0024	CcSEcCtD
Guanidine—Tension—Epirubicin—ovarian cancer	0.000388	0.00238	CcSEcCtD
Guanidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000386	0.00237	CcSEcCtD
Guanidine—Nervousness—Epirubicin—ovarian cancer	0.000384	0.00236	CcSEcCtD
Guanidine—Body temperature increased—Docetaxel—ovarian cancer	0.000378	0.00232	CcSEcCtD
Guanidine—Abdominal pain—Docetaxel—ovarian cancer	0.000378	0.00232	CcSEcCtD
Guanidine—Dizziness—Paclitaxel—ovarian cancer	0.000373	0.00229	CcSEcCtD
Guanidine—Anaemia—Epirubicin—ovarian cancer	0.000365	0.00224	CcSEcCtD
Guanidine—KCNH2—lymph node—ovarian cancer	0.000365	0.00121	CbGeAlD
Guanidine—Tension—Doxorubicin—ovarian cancer	0.000359	0.0022	CcSEcCtD
Guanidine—Rash—Paclitaxel—ovarian cancer	0.000356	0.00219	CcSEcCtD
Guanidine—Dermatitis—Paclitaxel—ovarian cancer	0.000356	0.00218	CcSEcCtD
Guanidine—Nervousness—Doxorubicin—ovarian cancer	0.000355	0.00218	CcSEcCtD
Guanidine—Leukopenia—Epirubicin—ovarian cancer	0.000354	0.00217	CcSEcCtD
Guanidine—Palpitations—Epirubicin—ovarian cancer	0.000349	0.00215	CcSEcCtD
Guanidine—SLC22A5—lymph node—ovarian cancer	0.000345	0.00114	CbGeAlD
Guanidine—Anaemia—Doxorubicin—ovarian cancer	0.000338	0.00208	CcSEcCtD
Guanidine—Nausea—Paclitaxel—ovarian cancer	0.000335	0.00206	CcSEcCtD
Guanidine—Dry mouth—Epirubicin—ovarian cancer	0.000329	0.00202	CcSEcCtD
Guanidine—Leukopenia—Doxorubicin—ovarian cancer	0.000327	0.00201	CcSEcCtD
Guanidine—Diarrhoea—Docetaxel—ovarian cancer	0.000327	0.00201	CcSEcCtD
Guanidine—Confusional state—Epirubicin—ovarian cancer	0.000325	0.002	CcSEcCtD
Guanidine—Palpitations—Doxorubicin—ovarian cancer	0.000323	0.00199	CcSEcCtD
Guanidine—Dizziness—Docetaxel—ovarian cancer	0.000316	0.00194	CcSEcCtD
Guanidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000316	0.00194	CcSEcCtD
Guanidine—Tachycardia—Epirubicin—ovarian cancer	0.000315	0.00193	CcSEcCtD
Guanidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000312	0.00192	CcSEcCtD
Guanidine—Anorexia—Epirubicin—ovarian cancer	0.000308	0.00189	CcSEcCtD
Guanidine—Dry mouth—Doxorubicin—ovarian cancer	0.000305	0.00187	CcSEcCtD
Guanidine—Rash—Docetaxel—ovarian cancer	0.000302	0.00185	CcSEcCtD
Guanidine—Hypotension—Epirubicin—ovarian cancer	0.000302	0.00185	CcSEcCtD
Guanidine—Dermatitis—Docetaxel—ovarian cancer	0.000301	0.00185	CcSEcCtD
Guanidine—Confusional state—Doxorubicin—ovarian cancer	0.000301	0.00185	CcSEcCtD
Guanidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000292	0.0018	CcSEcCtD
Guanidine—Tachycardia—Doxorubicin—ovarian cancer	0.000291	0.00179	CcSEcCtD
Guanidine—Paraesthesia—Epirubicin—ovarian cancer	0.00029	0.00178	CcSEcCtD
Guanidine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000289	0.00177	CcSEcCtD
Guanidine—Anorexia—Doxorubicin—ovarian cancer	0.000285	0.00175	CcSEcCtD
Guanidine—Nausea—Docetaxel—ovarian cancer	0.000284	0.00175	CcSEcCtD
Guanidine—Decreased appetite—Epirubicin—ovarian cancer	0.000281	0.00172	CcSEcCtD
Guanidine—Hypotension—Doxorubicin—ovarian cancer	0.000279	0.00171	CcSEcCtD
Guanidine—Paraesthesia—Doxorubicin—ovarian cancer	0.000268	0.00165	CcSEcCtD
Guanidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000266	0.00163	CcSEcCtD
Guanidine—Decreased appetite—Doxorubicin—ovarian cancer	0.00026	0.00159	CcSEcCtD
Guanidine—Abdominal pain—Epirubicin—ovarian cancer	0.000255	0.00157	CcSEcCtD
Guanidine—Body temperature increased—Epirubicin—ovarian cancer	0.000255	0.00157	CcSEcCtD
Guanidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000246	0.00151	CcSEcCtD
Guanidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000236	0.00145	CcSEcCtD
Guanidine—Abdominal pain—Doxorubicin—ovarian cancer	0.000236	0.00145	CcSEcCtD
Guanidine—Diarrhoea—Epirubicin—ovarian cancer	0.000221	0.00136	CcSEcCtD
Guanidine—Dizziness—Epirubicin—ovarian cancer	0.000213	0.00131	CcSEcCtD
Guanidine—Diarrhoea—Doxorubicin—ovarian cancer	0.000204	0.00125	CcSEcCtD
Guanidine—Rash—Epirubicin—ovarian cancer	0.000203	0.00125	CcSEcCtD
Guanidine—Dermatitis—Epirubicin—ovarian cancer	0.000203	0.00125	CcSEcCtD
Guanidine—Dizziness—Doxorubicin—ovarian cancer	0.000197	0.00121	CcSEcCtD
Guanidine—Nausea—Epirubicin—ovarian cancer	0.000192	0.00118	CcSEcCtD
Guanidine—Rash—Doxorubicin—ovarian cancer	0.000188	0.00116	CcSEcCtD
Guanidine—Dermatitis—Doxorubicin—ovarian cancer	0.000188	0.00115	CcSEcCtD
Guanidine—Nausea—Doxorubicin—ovarian cancer	0.000177	0.00109	CcSEcCtD
Guanidine—KCNQ3—Developmental Biology—IL6ST—ovarian cancer	0.000107	0.000657	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—CYP1B1—ovarian cancer	0.000107	0.000656	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—CYP1B1—ovarian cancer	0.000107	0.000656	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—CYP1B1—ovarian cancer	0.000107	0.000656	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000106	0.000653	CbGpPWpGaD
Guanidine—KCND3—Neuronal System—HRAS—ovarian cancer	0.000106	0.00065	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—SLC2A1—ovarian cancer	0.000106	0.000649	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—KRAS—ovarian cancer	0.000105	0.000646	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000104	0.000641	CbGpPWpGaD
Guanidine—KCNA1—Neuronal System—MAPK1—ovarian cancer	0.000104	0.00064	CbGpPWpGaD
Guanidine—KCNB1—Neuronal System—HRAS—ovarian cancer	0.000103	0.000634	CbGpPWpGaD
Guanidine—KCNH7—Neuronal System—MAPK1—ovarian cancer	0.000103	0.000631	CbGpPWpGaD
Guanidine—KCNH7—Circadian rythm related genes—IL6—ovarian cancer	0.000103	0.00063	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—CYP1B1—ovarian cancer	0.000101	0.000622	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000101	0.000619	CbGpPWpGaD
Guanidine—DLG4—Neuronal System—HRAS—ovarian cancer	0.000101	0.000618	CbGpPWpGaD
Guanidine—GAMT—Metabolism—ABCB1—ovarian cancer	0.000101	0.000618	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—CTNNB1—ovarian cancer	0.0001	0.000616	CbGpPWpGaD
Guanidine—ALDH2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.89e-05	0.000607	CbGpPWpGaD
Guanidine—GAMT—Metabolism—TYMS—ovarian cancer	9.89e-05	0.000607	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—MMP9—ovarian cancer	9.83e-05	0.000603	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.76e-05	0.000599	CbGpPWpGaD
Guanidine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	9.71e-05	0.000596	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—MMP9—ovarian cancer	9.6e-05	0.000589	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—MMP9—ovarian cancer	9.6e-05	0.000589	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PPP2R1A—ovarian cancer	9.48e-05	0.000582	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PPP2R1A—ovarian cancer	9.48e-05	0.000582	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PPP2R1A—ovarian cancer	9.48e-05	0.000582	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	9.48e-05	0.000582	CbGpPWpGaD
Guanidine—KCNQ1—Neuronal System—HRAS—ovarian cancer	9.44e-05	0.00058	CbGpPWpGaD
Guanidine—KCND2—Neuronal System—HRAS—ovarian cancer	9.44e-05	0.00058	CbGpPWpGaD
Guanidine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	9.38e-05	0.000576	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.36e-05	0.000574	CbGpPWpGaD
Guanidine—KCNH6—Neuronal System—HRAS—ovarian cancer	9.26e-05	0.000568	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MMP2—ovarian cancer	9.11e-05	0.000559	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MMP2—ovarian cancer	9.11e-05	0.000559	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.1e-05	0.000558	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—CASP3—ovarian cancer	9.07e-05	0.000557	CbGpPWpGaD
Guanidine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	9.05e-05	0.000556	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PPP2R1A—ovarian cancer	8.99e-05	0.000552	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—HRAS—ovarian cancer	8.94e-05	0.000549	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—VEGFA—ovarian cancer	8.83e-05	0.000542	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—ABCB1—ovarian cancer	8.8e-05	0.00054	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—ABCB1—ovarian cancer	8.8e-05	0.00054	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—ABCB1—ovarian cancer	8.8e-05	0.00054	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	8.75e-05	0.000537	CbGpPWpGaD
Guanidine—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	8.74e-05	0.000537	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—STAT3—ovarian cancer	8.74e-05	0.000537	CbGpPWpGaD
Guanidine—KCNQ2—Neuronal System—MAPK1—ovarian cancer	8.74e-05	0.000536	CbGpPWpGaD
Guanidine—KCNQ3—Neuronal System—MAPK1—ovarian cancer	8.74e-05	0.000536	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	8.72e-05	0.000535	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—NRAS—ovarian cancer	8.72e-05	0.000535	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—TYMS—ovarian cancer	8.65e-05	0.000531	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—TYMS—ovarian cancer	8.65e-05	0.000531	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—TYMS—ovarian cancer	8.65e-05	0.000531	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—VEGFA—ovarian cancer	8.62e-05	0.000529	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—VEGFA—ovarian cancer	8.62e-05	0.000529	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—IL6—ovarian cancer	8.56e-05	0.000525	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—NRAS—ovarian cancer	8.51e-05	0.000522	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—NRAS—ovarian cancer	8.51e-05	0.000522	CbGpPWpGaD
Guanidine—KCNA1—Neuronal System—HRAS—ovarian cancer	8.37e-05	0.000514	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—MAPK3—ovarian cancer	8.35e-05	0.000513	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—ABCB1—ovarian cancer	8.34e-05	0.000512	CbGpPWpGaD
Guanidine—KCNH7—Neuronal System—HRAS—ovarian cancer	8.25e-05	0.000507	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—TYMS—ovarian cancer	8.2e-05	0.000503	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—MAPK3—ovarian cancer	8.15e-05	0.0005	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—MAPK3—ovarian cancer	8.15e-05	0.0005	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—YAP1—ovarian cancer	8.04e-05	0.000494	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—ERBB2—ovarian cancer	7.98e-05	0.00049	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—ERBB2—ovarian cancer	7.98e-05	0.00049	CbGpPWpGaD
Guanidine—GAMT—Metabolism—CAV1—ovarian cancer	7.97e-05	0.000489	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.96e-05	0.000488	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—MAPK1—ovarian cancer	7.95e-05	0.000488	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—EGFR—ovarian cancer	7.94e-05	0.000488	CbGpPWpGaD
Guanidine—ALDH2—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.94e-05	0.000487	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.87e-05	0.000483	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.84e-05	0.000481	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYTB—ovarian cancer	7.84e-05	0.000481	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—MAPK1—ovarian cancer	7.76e-05	0.000476	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—MAPK1—ovarian cancer	7.76e-05	0.000476	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—EGFR—ovarian cancer	7.75e-05	0.000476	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—EGFR—ovarian cancer	7.75e-05	0.000476	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	7.7e-05	0.000473	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NME2—ovarian cancer	7.63e-05	0.000468	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.6e-05	0.000467	CbGpPWpGaD
Guanidine—ALDH2—Neuronal System—MAPK1—ovarian cancer	7.58e-05	0.000465	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.58e-05	0.000465	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—KRAS—ovarian cancer	7.51e-05	0.000461	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.4e-05	0.000454	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—KRAS—ovarian cancer	7.32e-05	0.00045	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—KRAS—ovarian cancer	7.32e-05	0.00045	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CG—ovarian cancer	7.26e-05	0.000446	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NME2—ovarian cancer	7.11e-05	0.000437	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.09e-05	0.000435	CbGpPWpGaD
Guanidine—KCNQ3—Neuronal System—HRAS—ovarian cancer	7.02e-05	0.000431	CbGpPWpGaD
Guanidine—KCNQ2—Neuronal System—HRAS—ovarian cancer	7.02e-05	0.000431	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—CTNNB1—ovarian cancer	6.98e-05	0.000429	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—CTNNB1—ovarian cancer	6.98e-05	0.000429	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—CAV1—ovarian cancer	6.97e-05	0.000428	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—CAV1—ovarian cancer	6.97e-05	0.000428	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—CAV1—ovarian cancer	6.97e-05	0.000428	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.9e-05	0.000423	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—BRIP1—ovarian cancer	6.85e-05	0.000421	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PPP1CC—ovarian cancer	6.85e-05	0.000421	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.85e-05	0.000421	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MMP9—ovarian cancer	6.85e-05	0.00042	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MMP9—ovarian cancer	6.85e-05	0.00042	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—CAV1—ovarian cancer	6.6e-05	0.000405	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—FASN—ovarian cancer	6.56e-05	0.000402	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—SLC5A5—ovarian cancer	6.45e-05	0.000396	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CD—ovarian cancer	6.38e-05	0.000392	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—HRAS—ovarian cancer	6.38e-05	0.000392	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CG—ovarian cancer	6.35e-05	0.000389	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CG—ovarian cancer	6.35e-05	0.000389	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CG—ovarian cancer	6.35e-05	0.000389	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—SLC2A1—ovarian cancer	6.23e-05	0.000382	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—HRAS—ovarian cancer	6.23e-05	0.000382	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—HRAS—ovarian cancer	6.23e-05	0.000382	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—VEGFA—ovarian cancer	6.15e-05	0.000377	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—VEGFA—ovarian cancer	6.15e-05	0.000377	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—IL6—ovarian cancer	6.11e-05	0.000375	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—STAT3—ovarian cancer	6.09e-05	0.000374	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—STAT3—ovarian cancer	6.09e-05	0.000374	CbGpPWpGaD
Guanidine—ALDH2—Neuronal System—HRAS—ovarian cancer	6.08e-05	0.000373	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—NRAS—ovarian cancer	6.07e-05	0.000373	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—NRAS—ovarian cancer	6.07e-05	0.000373	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CG—ovarian cancer	6.02e-05	0.000369	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6e-05	0.000368	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.98e-05	0.000367	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CYP1B1—ovarian cancer	5.97e-05	0.000367	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—IL6—ovarian cancer	5.96e-05	0.000366	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—IL6—ovarian cancer	5.96e-05	0.000366	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MAPK3—ovarian cancer	5.82e-05	0.000357	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MAPK3—ovarian cancer	5.82e-05	0.000357	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—AKT1—ovarian cancer	5.63e-05	0.000346	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CD—ovarian cancer	5.58e-05	0.000342	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CD—ovarian cancer	5.58e-05	0.000342	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CD—ovarian cancer	5.58e-05	0.000342	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CB—ovarian cancer	5.56e-05	0.000341	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—MAPK1—ovarian cancer	5.53e-05	0.00034	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—MAPK1—ovarian cancer	5.53e-05	0.00034	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—EGFR—ovarian cancer	5.53e-05	0.00034	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—EGFR—ovarian cancer	5.53e-05	0.00034	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.41e-05	0.000332	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—IL6—ovarian cancer	5.33e-05	0.000327	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PPP2R1A—ovarian cancer	5.3e-05	0.000325	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CD—ovarian cancer	5.29e-05	0.000325	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—KRAS—ovarian cancer	5.23e-05	0.000321	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—KRAS—ovarian cancer	5.23e-05	0.000321	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.94e-05	0.000303	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ABCB1—ovarian cancer	4.92e-05	0.000302	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYTB—ovarian cancer	4.92e-05	0.000302	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CB—ovarian cancer	4.86e-05	0.000298	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CB—ovarian cancer	4.86e-05	0.000298	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CB—ovarian cancer	4.86e-05	0.000298	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—TYMS—ovarian cancer	4.83e-05	0.000296	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PTEN—ovarian cancer	4.81e-05	0.000295	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.77e-05	0.000293	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CB—ovarian cancer	4.61e-05	0.000283	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.6e-05	0.000282	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—YAP1—ovarian cancer	4.6e-05	0.000282	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYTB—ovarian cancer	4.58e-05	0.000281	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.44e-05	0.000273	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—HRAS—ovarian cancer	4.44e-05	0.000273	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—HRAS—ovarian cancer	4.44e-05	0.000273	CbGpPWpGaD
Guanidine—KCNH2—Neuronal System—MAPK1—ovarian cancer	4.35e-05	0.000267	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—BRIP1—ovarian cancer	4.3e-05	0.000264	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PPP1CC—ovarian cancer	4.3e-05	0.000264	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—IL6—ovarian cancer	4.25e-05	0.000261	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—IL6—ovarian cancer	4.25e-05	0.000261	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PTEN—ovarian cancer	4.2e-05	0.000258	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PTEN—ovarian cancer	4.2e-05	0.000258	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PTEN—ovarian cancer	4.2e-05	0.000258	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PPP1CC—ovarian cancer	4.01e-05	0.000246	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—BRIP1—ovarian cancer	4.01e-05	0.000246	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PTEN—ovarian cancer	3.98e-05	0.000244	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—AKT1—ovarian cancer	3.92e-05	0.000241	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—AKT1—ovarian cancer	3.92e-05	0.000241	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CAV1—ovarian cancer	3.89e-05	0.000239	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.76e-05	0.000231	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—FASN—ovarian cancer	3.75e-05	0.00023	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—SLC5A5—ovarian cancer	3.69e-05	0.000226	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—SLC2A1—ovarian cancer	3.56e-05	0.000219	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.55e-05	0.000218	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CG—ovarian cancer	3.55e-05	0.000218	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.51e-05	0.000215	CbGpPWpGaD
Guanidine—KCNH2—Neuronal System—HRAS—ovarian cancer	3.49e-05	0.000214	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP1B1—ovarian cancer	3.41e-05	0.000209	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CA—ovarian cancer	3.39e-05	0.000208	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.3e-05	0.000203	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CD—ovarian cancer	3.12e-05	0.000191	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PPP2R1A—ovarian cancer	3.03e-05	0.000186	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CA—ovarian cancer	2.96e-05	0.000182	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CA—ovarian cancer	2.96e-05	0.000182	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CA—ovarian cancer	2.96e-05	0.000182	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—YAP1—ovarian cancer	2.88e-05	0.000177	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.85e-05	0.000175	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ABCB1—ovarian cancer	2.81e-05	0.000173	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CA—ovarian cancer	2.81e-05	0.000172	CbGpPWpGaD
Guanidine—GAMT—Metabolism—AKT1—ovarian cancer	2.77e-05	0.00017	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—TYMS—ovarian cancer	2.76e-05	0.000169	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CB—ovarian cancer	2.72e-05	0.000167	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—MAPK1—ovarian cancer	2.72e-05	0.000167	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—YAP1—ovarian cancer	2.69e-05	0.000165	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.65e-05	0.000163	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—MAPK1—ovarian cancer	2.53e-05	0.000155	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—AKT1—ovarian cancer	2.42e-05	0.000149	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—AKT1—ovarian cancer	2.42e-05	0.000149	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—AKT1—ovarian cancer	2.42e-05	0.000149	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—FASN—ovarian cancer	2.35e-05	0.000144	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PTEN—ovarian cancer	2.35e-05	0.000144	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC5A5—ovarian cancer	2.31e-05	0.000142	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—AKT1—ovarian cancer	2.3e-05	0.000141	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC2A1—ovarian cancer	2.23e-05	0.000137	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CAV1—ovarian cancer	2.22e-05	0.000137	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—FASN—ovarian cancer	2.19e-05	0.000134	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—HRAS—ovarian cancer	2.18e-05	0.000134	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SLC5A5—ovarian cancer	2.15e-05	0.000132	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP1B1—ovarian cancer	2.14e-05	0.000131	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SLC2A1—ovarian cancer	2.08e-05	0.000128	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—HRAS—ovarian cancer	2.03e-05	0.000125	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CG—ovarian cancer	2.03e-05	0.000124	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP1B1—ovarian cancer	2e-05	0.000122	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.9e-05	0.000117	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CD—ovarian cancer	1.78e-05	0.000109	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	1.77e-05	0.000109	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.76e-05	0.000108	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—TYMS—ovarian cancer	1.73e-05	0.000106	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CA—ovarian cancer	1.66e-05	0.000102	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ABCB1—ovarian cancer	1.64e-05	0.000101	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TYMS—ovarian cancer	1.61e-05	9.9e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CB—ovarian cancer	1.55e-05	9.53e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CAV1—ovarian cancer	1.4e-05	8.56e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—AKT1—ovarian cancer	1.35e-05	8.3e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PTEN—ovarian cancer	1.34e-05	8.23e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CAV1—ovarian cancer	1.3e-05	7.98e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	1.27e-05	7.8e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CG—ovarian cancer	1.18e-05	7.27e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	1.12e-05	6.86e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CD—ovarian cancer	1.04e-05	6.39e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	9.74e-06	5.98e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CA—ovarian cancer	9.46e-06	5.81e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CB—ovarian cancer	9.08e-06	5.57e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PTEN—ovarian cancer	8.41e-06	5.16e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PTEN—ovarian cancer	7.84e-06	4.81e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—AKT1—ovarian cancer	7.73e-06	4.75e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	5.94e-06	3.64e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	5.53e-06	3.4e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—AKT1—ovarian cancer	4.85e-06	2.98e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—AKT1—ovarian cancer	4.52e-06	2.77e-05	CbGpPWpGaD
